The EU has recommended lenacapavir, an injectable drug for HIV prevention, which could drastically reduce transmission rates. With nearly 100% effectiveness, it promises a new era in combating HIV.
The UNAIDS annual report warns that decades of progress in combating HIV/AIDS are jeopardized by significant funding cuts, particularly from U.S. donors, threatening millions of lives in the coming years.
Recent U.S. funding cuts to AIDS programs have sparked alarms, with UNAIDS warning of potential catastrophic rises in HIV infections and AIDS-related deaths. The future of global health hangs in the balance.
